Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghaith Aljayyoussi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Emerging Infectious Diseases|September 12, 2020
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 DiagnosisRachel L Byrne, Grant A Kay, Konstantina Kontogianni, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
Bioorganic & Medicinal Chemistry|May 22, 2018
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malariaPaul M O' Neill, Paul A Stocks, Sunil Sabbani, et al.
Plos Neglected Tropical Diseases|January 17, 2019
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection modelsHanna T Sjoberg, Nicolas Pionnier, Ghaith Aljayyoussi, et al.
Journal of Medicinal Chemistry|March 18, 2017
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosisW David Hong, Peter D Gibbons, Suet C Leung, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Emerging Infectious Diseases|September 12, 2020
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 DiagnosisRachel L Byrne, Grant A Kay, Konstantina Kontogianni, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
Bioorganic & Medicinal Chemistry|May 22, 2018
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malariaPaul M O' Neill, Paul A Stocks, Sunil Sabbani, et al.
Plos Neglected Tropical Diseases|January 17, 2019
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection modelsHanna T Sjoberg, Nicolas Pionnier, Ghaith Aljayyoussi, et al.
Journal of Medicinal Chemistry|March 18, 2017
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosisW David Hong, Peter D Gibbons, Suet C Leung, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Pageof 5